Effects of the glycoprotein IIb/IIIa antagonist Roxifiban on P-selectin expression, fibrinogen binding, and microaggregate formation in a phase I dose-finding study: no evidence for platelet activation during treatment with a glycoprotein IIb/IIIa antagonist

By Seiffert Dietmar   Thomas Beth E.   Bradley Jodi D.   Munzer Deborah A.   Tchinnes Maureen A.   Kornhauser David M.   Cain Valerie A.   Hua Tsuhung A.   Feuerstein Giora Z.   Martin David E.   Stern Andrew M.  

Platelets, Vol. 14, Iss. 3, 2003-05 ,pp. : 179-187

Informa Healthcare

Access to resources Recommend Favorite

Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists

By Sirotkina Olga   Khaspekova Svetlana   Zabotina Anna   Shimanova Yulia   Mazurov Alexey  

Platelets, Vol. 18, Iss. 7, 2007-11 ,pp. : 506-514

Informa Healthcare

Access to resources Recommend Favorite

Use of glycoprotein IIb/IIIa receptor antagonist in prosthetic valve thrombosis

By Caceres-Loriga F.   Santos-Gracia J.  

Platelets, Vol. 21, Iss. 7, 2010-11 ,pp. : 583-583

Informa Healthcare

Access to resources Recommend Favorite

BIOLOGICAL MATRIX-DEPENDENT PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS OF A NOVEL PLATELET GLYCOPROTEIN IIB/IIIA RECEPTOR ANTAGONIST, XU063, IN BEAGLE DOGS

By Kapil R.P.   Emm T.A.   Mousa S.A.   Padovani P.K.   Quon C.Y.   Lam G.N.  

Thrombosis Research, Vol. 86, Iss. 3, 1997-05 ,pp. : 221-232

Elsevier

Access to resources Recommend Favorite

Platelet Glycoprotein IIb/IIIa Blockade in Acute Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 11, Iss. 4, 2001-05 ,pp. : 287-293

Karger

Access to resources Recommend Favorite